• Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell Badge R. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126140.
  • Bhakdi S, Bayley H, Valeva A, Walev I, Walker B, Kehoe M, Palmer M. 1996. Staphylococcal alpha-toxin, streptolysin-O and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol 165: 7379.
  • Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, Wheeler R, Wong B, Drenkow J, Yamanaka M, Patel S, Brubaker S, Tammana H, Helt G, Struhl K, Gingeras TR. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499509.
  • Collas P. Reprogramming somatic cells in extract of undifferentiated carcinoma cells. Available at:
  • Cowan CA, Atienza J, Melton DA, Eggan K. 2005. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 13691373.
  • Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. 2003. Genomic targets of the human c-Myc protein. Genes Dev 17: 11151129.
  • Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P. 2004. Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem Biophys Res Commun 14: 420427.
  • Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. 2004. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7: 165171.
  • McGann CJ, Odelberg SJ, Keating MT. 2001. Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci USA 98: 1369913704.
  • Miyamoto K, Furusawa T, Ohnuki M, Goel S, Tokunaga T, Minami N, Yamada M, Ohsumi K, Imai H. 2007. Reprogramming events of mammalian somatic cells induced by Xenopus laevis egg extracts. Mol Reprod Dev 74: 12681277.
  • Nakagawa M, Koyanagi M, Tanabe K. 2008. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26: 101106.
  • Pesce M, Schöler HR. 2000. Oct-4: control of totipotencyand germline determination. Mol Reprod Dev 55: 452457.
  • Rowland BD, Bernards R, Peeper DS. 2005. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 7: 10741082.
  • Shi Y, Do JT, Desponts C, Hahm HS, Schöler HR, Ding S. 2008. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525528.
  • Sullivan EJ, Kasinathan S, Kasinathan P, Robl JM, Collas P. 2004. Cloned calves from chromatin remodeled in vitro. Biol Reprod 70: 146153.
  • Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. 2001. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 11: 15531558.
  • Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663676.
  • Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861872.
  • Taranger CK, Noer A, Sørensen AL, Håkelien AM, Boquest AC, Collas P. 2005. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol Biol Cell 16: 57195735.
  • Walev I, Hombach M, Bobkiewicz W, Fenske D, Bhakdi S, Husmann M. 2002. Resealing of large transmembrane pores produced by streptolysin O in nucleated cells is accompanied by NF-kappaB activation and downstream events. FASEB J 16: 237239.
  • Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. 2007. Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 19171920.